Najat Khan Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity
Najat Khan is Chief R&D Commercial Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 496,972 shares of RXRX, which is worth approximately $3.53 Million. The most recent transaction as insider was on Aug 01, 2024, when has been sold 496,972 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
497K
0%
3M change
n/a
12M change
Total Value Held
$3.53 Million
NK
Najat Khan
Chief R&D Commercial Officer
Salt Lake City, UT